Estradiol Valerate/Dienogest: profile report

&NA;

doi:10.2165/00042310-200218060-00001

Estradiol Valerate/Dienogest: profile report

&NA;

In: Drugs & Therapy Perspectives · 2002 · vol. 18(6) , pp. 1–3 · doi:10.2165/00042310-200218060-00001 · W4234697249

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex

⚙ AI-generated summary by qwen3.7-flash, 2026-09-03 ⓘ

This report provides a profile of the estradiol valerate/dienogest combination, though specific findings related to endometriosis or adenomyosis are not detailed in the provided text.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (10)

Climodien<sup>®</sup>(estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints via openalex
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest<sup>®</sup>for continuous combined hormone replacement therapy in postmenopausal women via openalex
doi:10.1016/s0015-0282(01)01791-5 via openalex
doi:10.1016/s0015-0282(01)01792-7 via openalex
doi:10.1177/136218079500100211 via openalex
doi:10.2165/00003495-200262030-00006 via openalex
doi:10.2165/00003495-200262030-00008 via openalex
doi:10.1016/s0002-9378(99)70438-2 via openalex
doi:10.1016/s0140-6736(98)05352-5 via openalex
doi:10.1016/0029-7844(94)00383-o via openalex

Source provenance

openalex: last seen: 2026-05-10T11:11:12.335017+00:00

License: CC0 · commercial use OK

[1] Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest<sup>®</sup>for continuous combined hormone replacement therapy in postmenopausal women 2000

[2] Climodien<sup>®</sup>(estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints 2001